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Abstract. Intensity modulated radiotherapy (IMRT) is one 
of the modern conformal radiotherapies that is widely used 
within the context of cancer patient treatment. It uses multiple 
radiation beams targeted to the tumor, however, large 
volumes of the body receive low doses of irradiation. Using 
γ-H2AX and global genome expression analysis, we studied 
the biological responses induced by low doses of ionizing 
radiation in prostate cancer patients following IMRT. By 
means of different bioinformatics analyses, we report that 
IMRT induced an inflammatory response via the induction 
of viral, adaptive, and innate immune signaling. In response 
to growth factors and immune-stimulatory signaling, posi-
tive regulation in the progression of cell cycle and DNA 
replication were induced. This denotes pro-inflammatory 
and pro-survival responses. Furthermore, double strand 
DNA breaks were induced in every patient 30 min after the 
treatment and remaining DNA repair and damage signaling 
continued after 18-24 h. Nine genes belonging to inflam-
matory responses (TLR3, SH2D1A and IL18), cell cycle 
progression (ORC4, SMC2 and CCDC99) and DNA damage 
and repair (RAD17, SMC6 and MRE11A) were confirmed by 
quantitative RT-PCR. This study emphasizes that the risk 
assessment of health effects from the out-of-field low doses 
during IMRT should be of concern, as these may increase 
the risk of secondary cancers and/or systemic inflammation.
Introduction
Currently, intensity modulated radiotherapy (IMRT) is a 
widely applied conformal radiotherapy modality; in contrast 
to conventional radiotherapy, IMRT uses multiple beams 
across the target field of treatment. This reduces the volume 
of tissues receiving high doses, but a greater volume of normal 
tissues still receives low doses of radiation (1-3). It is estimated 
that IMRT can contribute to 1.5% increased risk of secondary 
cancers by 10 years following treatment (4). However, these 
figures were considered to be overestimated because the calcu-
lations of these risks were based on the long-term data obtained 
from the follow-up of atomic bomb survivors. This population 
was exposed to a single whole body dose, while IMRT patients 
receive fractionated doses to specific body parts (5). Besides, 
other studies moderated the therapeutic effect of IMRT over 
its potential health side effects (6,7).
Microarrays and DNA damage studies, through measuring 
the Ser 139 phosphorylated form of histone H2AX (γ-H2AX), 
are emerging applications in the field of radiation biology and 
biodosimetry. Gene expression studies improved the knowl-
edge on cellular responses to both high and low radiation doses 
(8-11). On the other hand, γ-H2AX foci immunodetection has 
been described as useful quantitative biomarker of human low-
level radiation exposure (12).
In this study, we address the question of understanding 
the whole blood tissue biological responses in prostate cancer 
patients receiving low doses of ionizing radiation during 
IMRT. It is the first study that combines DNA damage and 
microarray investigations on whole blood samples collected 
in vivo from patients receiving low doses over a large part of 
the body. It highlights the mechanisms and the possible health 
effects involved in response to low doses of ionizing radiation. 
For the DNA damage assessment γ-H2AX foci were scored. 
For the analysis of the microarray data, we applied a holistic 
approach, namely Gene Set Enrichment Analysis (GSEA) that 
it is known to overcome many of the limitations in individual 
gene pathway analysis, discussed thoroughly by Subramanian 
and colleagues (13). In addition, we used differentially 
expressed genes for Exploratory Gene Association Networks 
(EGAN) analysis.
Materials and methods
Patients and sample collection. The study population consisted 
of 8 prostate cancer patients treated with step and shoot-
IMRT (ss-IMRT) (Elekta Synergy linear accelerator) at the 
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Department of Radiation Oncology (Ghent University Hospital, 
Belgium) between March and May 2013. A dose per fraction 
to the tumor was 2.09 Gy. After obtaining written approval of 
the ethics committee at Ghent University Hospital and signed 
informed consent, blood samples were taken at different time-
points. Blood sampling for the γ-H2AX foci was performed in 
heparin vacutainer tubes before and 30 min after the first frac-
tion, blood sampling for the whole genome expression analysis 
was performed in EDTA vacutainer tubes before the first and 
second fraction, 18-24 h after the first fraction.
Dose calculation. The equivalent total body blood dose 
(DETB) was calculated for each patient based on the treat-
ment planning data. To this end, the mean dose within the skin 
contour of the scanned volume was normalised to the patient 
mass. As liver, heart/large blood vessels and lungs contain 
together 38.5% of the total blood volume it was assumed that 
61.5% of the blood pool is distributed uniformly over the rest 
of the body.
γ-H2AX scoring. The procedure for the γ-H2AX foci assay 
on T-lymphocytes is described in detail in a previous report 
(14). Foci analysis was performed with the Cytovision v.2.8 
Software 2002 (Applied Imaging, USA) and an Olympus 
BX60 fluorescent microscope was used with a 100x/1.30 oil 
lens. Several images of one slide were captured with a digital 
camera (Applied Imaging), 10 Z-stacks with 1.03 µm spacing 
was used.
RNA isolation for microarray gene expression studies. 
Collected venous blood (4-ml/time-point) was passed through 
a LeukoLOCK™ filter (Life Technologies, USA), washed 
with PBS and leukocytes were stabilized with RNAlater®. 
Filters were capped and stored at -20˚C. RNA was isolated 
using LeukoLOCK™ Isolation System (Life Technologies) 
according to the manufacturer's instructions. RNA was 
quantified using a Nanodrop 2000 (Thermo Scientific, 
USA) spectrophotometer, the quality was assessed with 
Agilent 2100 Bioanalyzer. All RNA samples had ≥8.5 as an 
integrity number.
Microarray assay. Using the Ambion® WT Expression kit 
(Ambion, USA), cDNA was prepared from 10 µg of purified 
cRNA, originally synthesized and purified from 0.25 µg of 
total RNA, following the manufacturer's instructions. The 
cDNA (2.75 µg) was used for fragmentation and labeling 
using GeneChip® Terminal Labeling kit (Affymetrix, 
USA). Using GeneChip® Hybridization, Wash and Stain 
kit (hybridization module) (Affymetrix), and hybridization 
controls (Affymetrix), fragmented and labeled cDNA was 
hybridized to Human Gene 1.0 ST arrays (Affymetrix). 
After hybridization with rotation for 16 h at 45˚C, arrays 
were washed and stained, according to the manufacturer's 
instructions, using GeneChip® Hybridization, Wash and 
Stain kit (stain module) (Affymetrix). Finally, arrays 
were scanned immediately using Affymetrix GeneChip® 
Scanner.
Microarray data processing. Raw Affymetrix data were 
preprocessed using Partek Genomics Suite v6.6 (Partek Inc., 
USA). Briefly, Robust Multichip Average (RMA) was used for 
background correction followed by quantile normalization and 
summarization of multiple probe intensities for each probeset 
using the median polish approach (15). Gene expression values 
were obtained by the one-step Tukey method.
Functional analysis - GSEA. GSEA calculates an enrich-
ment score (ES) reflecting the overrepresentation of a certain 
gene set at the top or bottom of a ranked list of genes found 
in the expression dataset of two classes. This method applies 
the Kolmogorov-Smirnov test to find deviation between two 
distributions. Information on GSEA was reported previ-
ously (13). Briefly, genes are ranked using signal-to-noise 
ratio. Using Kolmogorov-Smirnov statistics, pre-defined sets 
of genes are scored and significance is tested by empirical 
permutation followed by correction for multiple hypotheses. 
The Reactome database was used as reference background 
for the implemented analysis. In total, the data were analyzed 
against 674 gene sets downloaded from the Molecular 
Signature Database (MSigDB) (http://www.broadinstitute.org/
gsea/msigdb/index.jsp). The GSEA software parameters were 
set to their default values. The statistical significance of the 
normalized enrichment score (NES) associated to each gene 
set was assessed through 1,000 random permutations of the 
phenotypic labels. FDR (false discovery rate) value <0.05 
was used as a cut-off value for assessing the statistical signifi-
cance of the estimates. For gene set networks, we used the 
Enrichment Map plug-in (16) for Cytoscape Desktop program 
(http://baderlab.org/Software/EnrichmentMap/). Gene sets 
with FDR values <0.05 and having ≥50% overlapping genes 
are represented in the network.
Functional analysis - Exploratory Gene Association Networks. 
To test for differential expression between different irradiated 
conditions and reference conditions (no irradiation) we used 
repeated measures ANOVA. Differentially expressed genes 
were defined with a p-value cutoff with a false discovery 
rate of <0.05. Differentially expressed genes were analyzed 
using Exploratory Gene Association Networks (EGAN, The 
Regents of the University of California) software to determine 
differentially regulated pathways. P-values were corrected 
using Westfall-Young minP method. P-values <0.05 were 
considered significant. For clearer illustrations, not all genes 
belonging to each pathway are shown in the figures.
Quantitative RT-PCR validation. For quantitative real-time 
(RT-PCR) confirmation, we selected nine different genes 
that were shown to be differentially expressed and contrib-
uted to the pathway enrichment of immune signaling, DNA 
damage and repair and cell cycle progression. Briefly, cDNA 
was prepared from 0.25 µg of total RNA using Ambion® 
WT Expression kit (Ambion) following the manufacturer's 
instructions. RT-PCR was performed using TaqMan® Gene 
Expression assays (Applied Biosystems, USA). Each TaqMan 
assay was run in duplicate for each diluted cDNA sample using 
TaqMan® Fast Advanced Master Mix (Applied Biosystems). 
The reactions were run on ABI 7500 Fast RT-PCR system 
following the manufacturer's recommended PCR program: 
95˚C for 20 sec, followed by 40 cycles of 95˚C for 3 sec and 
60˚C for 30 sec. Relative expression values were calculated 
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by Pfaffl (17) method normalized to PGK1 levels. Relative 
expression levels were tested for statistical significance using 
paired t-test, genes having p-values <0.05 were considered 
significant.
Results
Based on the treatment planning data the equivalent total body 
dose of one fraction amounted to 30.97±8.12 mGy (Table III). 
GSEA enrichment map analysis showed interconnections of 
4 different signal transduction categories; these are immune 
signaling, growth factors signaling, cell cycle progression and 
survival, as well as DNA damage and repair (Fig. 1). On the 
other hand, EGAN analysis showed the biological response is 
divided into three different categories: growth factors and cell 
cycle progression, viral and immune signaling and metabolism 
(Table II and Fig. 2).
Low doses of ionizing radiation induces pro-inflammatory 
response via the activation of viral, adaptive and innate 
immune signaling. HIV infection and gene sets belonging 
to the adaptive immune response contributed mainly to 
the enrichment of the immune signaling cluster (Table I). 
The involvement of the viral infection response, along with 
interferon signaling and secretion and APOBEC3G degra-
dation denotes the induction of an inflammatory response 
accompanied by DNA damage; the HIV infection node 
shared a common edge with the DNA damage and repair 
gene sets (Fig. 1). Furthermore, the enrichment map analysis 
showed involvement of adaptive immune response activa-
tion, particularly CD28 stimulation that works in an opposite 
way with CTLA4, leading to T-cell receptor activation and 
cytokine secretion (Table I and Fig. 1). In addition, innate 
immune gene sets were significantly modulated; these include 
phagosome pathway, inflammasomes, toll-like receptors and 
NOD-like receptors (Table I and Fig. 1). Similar to GSEA, 
EGAN analysis showed the enrichment of signaling involved 
in viral immune responses. The viral signaling network was 
composed of several immune-related pathways, namely virus 
replication, IκB proteins and toll-like receptors. Furthermore, 
it showed connection with DNA damage and repair node, 
which is a characteristic of a viral response (Fig. 3 and 
Table II).
Among the upregulated genes that contributed to the 
positive regulation of inflammatory response are SH2D1A, 
TLR3 and IL18 (Figs. 3 and 7A).
Figure 1. Enrichment map analysis of GSEA results. Each gene set is represented by a node with different size, proportional to the number of genes; the con-
necting line represents the percentage of overlap and its thickness represents the percentage of overlapping. Black nodes represent upregulated gene sets, whilst 
white nodes represent downregulated gene sets. A combination of two cut-offs was applied: 5% FDR and a minimum of 50% gene overlapping.
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Low doses of ionizing radiation induces pro-survival response 
via immune-stimulation and cell cycle progression responses 
downstream growth factors signaling. Individual gene path-
ways analysis showed the downregulation of several growth 
Table I. Statistical significance of GSEA Reactome database gene sets.
Category  Gene set Size of gene set FDR q-value
Immune signaling HIVa infection 181 <0.0001
 Interferon secretion 63 <0.0001
 NEPb/SEP2c viral proteins 25 <0.0001
 Activation of APOE3Gd degradation via VIFe 47   0.001
 CD28f stimulation 56   0.004
 Antigen processing and presentation 183   0.006
 BCRg activation 115   0.02
 TCRh activation 13   0.009
 Phagosome pathway 55   0.01
 Adaptive immune response 460   0.013
 Inhibition of CTLA4i 20   0.013
 Inflammasomes 15   0.02
 Activation of NFκB 60   0.031
 Activation of TLRj signaling 11   0.03
 Cytokine signaling 237   0.041
 NLRk signaling 38   0.042
 IL7 signaling 10   0.045
 PD1l signaling 15   0.047
Cell cycle Mitotic cell cycle 278 <0.0001
 Degradation of mitotic proteins via CDC20m 61 <0.0001
 Degradation of CDH1n 54 <0.0001
 Removal of CDC6o 45 <0.0001
 DNA replication 170 <0.0001
 Chromosome maintenance 100   0.028
 ORC1p removal 58   0.003
DNA damage and repair DNA repair 91 <0.0001
 Formation of NERq complex 17   0.0009
 Fanconi anemia 16   0.001
Growth signaling FGFRr activation 21 <0.0001
 SHCs cascade 25   0.001
 PI3Kt cascade 51   0.029
 IGFBPsu  14   0.023
Metabolism Amino acids metabolism 16 <0.0001
 Metabolism of lipids 19   0.001
 Metabolism of proteins 24   0.002
 TCAv cycle 105   0.006
 Glucose transport  36   0.031
aHIV, human immunodeficiency virus; bNEP, nuclear export protein; cSEP2, septin-2; dAPOBEC3G, apolipoprotein B mRNA-editing, enzyme-
catalytic, polypeptide-like 3G; eVIF, viral infectivity factor; fCD28, custer of differentiation 28; gBCR, B-cell receptor; hTCR, T-cell receptor; 
iCTLA4, cytotoxic T-lymphocyte antigen 4; jTLR, toll-like receptor; kNLR, NOD-like-receptor; lPD1, programmed death 1; mCDC20, cell 
divion cycle protein 20; nCDH1, cadherin-1; oCDC6, cell divion control protein 6 homolog; pORC1, origin recognition complex subunit 1; 
qNER, nucleotide excision repair; rFGFR, fibroblast growth factor receptor; sSHC, Src homomogy 2 domain containing transforming protein; 
tPI3K, phosphatidylinositol 3- and 4-kinase; uIGFBP, insulin growth factor binding proteins; vTCA, tricarboxylic acid cycle.
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Figure 2. EGAN analysis showing all the differentially expressed enriched pathway genes. Each circle represents a gene. Dark gray circles are upregulated 
genes; light gray circles are downregulated genes. The lines represent connections between different genes belonging to different pathways.
Figure 3. EGAN analysis showing the viral response network. The viral response network is composed from virus replication, IκB proteins, toll-like receptors 
and DNA damage and repair pathways. Each circle represents a gene. Dark gray circles are upregulated genes; light gray circles are downregulated genes. The 
lines represent connections between different genes belonging to different pathways.
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factors like fibroblast growth factors (FGFs), insulin growth 
factor I (IGF-I), extracellular proteins and platelet-derived 
growth factor signaling (PDGF) (Table II). Downstream to 
growth factor signaling, DNA replication and mitotic cell 
cycle networks were shown to be upregulated (Fig. 4).
Similarly, GSEA and EGAN showed downregulation 
of gene sets involved in fibroblast growth factor signaling. 
These nodes showed a connection with the adaptive immune 
response gene set and immune-related network, respectively 
Table II. Enriched pathways of the differentially expressed 
genes.
Pathway p-value
Growth factors signaling and cell cycle
progression
 Extracellular matrix proteins  1.16E-19
 Extracellular signal regulated MAP kinases 2.90E-16
 Mitotic cell cycle 8.70E-16
 Insulin growth factor I 2.30E-15
 Fibroblast growth factors 3.45E-11
 DNA replication 1.98E-10
 Signaling by platelet derived growth factor  2.80E-04
Viral and immune response
 Virus replication 2.80E-06
 DNA damage and repair 4.90E-06
 Toll-like receptors 5.40E-06
 IκB proteins  1.90E-05
Metabolism
 Metabolism of lipids and lipoproteins 1.40E-05
 Metabolism of proteins  5.40E-04
 RNA degradation  6.40E-04
Figure 4. EGAN analysis showing the network between growth factor signaling (fibroblast growth factors, insulin growth factor I, extracellular matrix proteins 
and ERK MAPKs) and their effect on the positive regulation of cell cycle (mitotic cell cycle and DNA replication). Each circle represents a gene. Dark gray 
circles are upregulated genes; light gray circles are downregulated genes. The lines represent connections between different genes belonging to different 
pathways.
Table III. Number of induced γ-H2AX foci and the equivalent 
total body dose (ETBD) in the eight prostate cancer patients 
30 min post-IMRT.
 Induced foci/cell ETBD (mGy)
Patient 1 0.622 28.01
Patient 2 0.584 46.34
Patient 3 0.267 30.24
Patient 4 0.674 33.79
Patient 5 0.583 37.94
Patient 6 0.561 25.54
Patient 7 0.28 22.07
Patient 8 0.194 23.86
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(Figs. 1 and 5). Downstream immune-related nodes were 
connected to the positive cell cycle progression and survival 
via the induction of the gene sets involved in CDC20, ORC1 
and CDH1 degradation and promotion of DNA replication 
(Figs. 1 and 6). Among the upregulated genes contributing to 
the positive regulation of cell cycle progression are CCDC99, 
ORC4 and SMC2 (Figs. 4 and 7B).
Low doses of ionizing radiation induces increased DNA 
damage. For all patients an increase of the γ-H2AX foci yield 
was observed: 0.47±0.19 foci/cell (Table III). Furthermore, 
after 18-24 h, significantly upregulated enriched gene sets were 
determined, and differently expressed genes that are linked to 
DNA damage and repair signaling like RAD17, MRE11A, and 
SMC6 were found (Figs. 3 and 7C).
Discussion
We investigated in vivo the biological responses to low doses 
of ionizing radiation. To this end, we assessed DNA damage, 
through scoring of γ-H2AX foci, and performed whole 
genome analysis followed by qRT-PCR validation (Fig. 7) on 
whole blood samples collected from prostate cancer patients 
undergoing IMRT. Whole blood samples were collected from 
prostate cancer patients before, and at 30 min (for γ-H2AX 
studies), and 18-24 h (for microarray studies) after the first 
Figure 5. EGAN analysis showing the network between growth factors and their effect on immune-stimulation. The ‘Immune node’ is the viral response 
network from Fig. 3. Each circle represents a gene. Dark gray circles are upregulated genes; light gray circles are downregulated genes. The lines represent 
connections between different genes belonging to different pathways.
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fraction of irradiation. We chose to perform the experiments 
on whole blood samples as these are composed of a complex 
combination of different cell types; therefore, it allows the 
study of a collective tissue response. On the other hand, blood 
is a circulating tissue, thus it reflects the response to the calcu-
lated equivalent total body dose.
Prostate cancer patients show induction of pro-inflammatory 
response via the activation of viral signaling. Previously, we 
demonstrated that low doses of ionizing radiation induce a 
unique gene expression profile compared to high doses (11). 
The low doses are characterized by the induction of stimula-
tory immune response through the activation of chemokine 
and cytokine signaling, while high doses are characterized by 
a damaging response through p53 signaling. In agreement with 
these results, current GSEA showed the enrichment of several 
immune signaling pathways; top ranked gene sets were related 
to viral signaling, in specific human immunodeficiency virus 
(HIV) infection signaling and interferon secretion (Table I). 
Viral response is composed of signaling network between 
NF-κB, ERK 1/2 MAP kinase and p38 MAP kinase pathways. 
Furthermore, it is known that ionizing radiation is able to acti-
vate HIV promoter and gene expression in T cells. The gene 
expression of HIV viral infections are regulated by various 
cell signaling events that combine mitogens, cytokines, stress, 
and DNA damage (18). In other words, the enrichment of the 
HIV-infection and interferon gene sets in our data suggests a 
‘communication network’ between DNA damage and central 
pathways in the immune response (Figs. 1 and 3). In addition, 
to that, other viral-related gene sets were also shown to be 
upregulated; these are NEP/SEP viral proteins, subset of the 
HIV-infection gene set, and degradation of APOBEC3G via 
VIF (viral infectivity factor). APOBEC3G is a protein that 
plays a role in activating an antiviral response; its degradation 
denotes an amplification of viral and inflammatory response 
(19). One of the key genes that plays a role in response to viral 
infections is the toll-like receptor 3 (TLR3) (Fig. 7A), after 
viral infection TLR3 recognizes double strand RNA (dsRNA) 
that leads to downstream activation of type I interferons and 
NF-κB, a proinflammatory and prosurvival pathway (20,21). 
Figure 6. EGAN analysis showing the network between immune-stimulation and their effect on cell cycle progression (mitotic cell cycle and DNA replication). 
The immune node is the viral response network from Fig. 3. Each circle represents a gene. Dark gray circles are upregulated genes; light gray circles are 
downregulated genes. The lines represent connections between different genes belonging to different pathways.
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TLR3 was reported also to be activated upon interaction with 
exogenous and endogenous RNA molecules (22). Furthermore, 
GSEA showed the enrichment of TLR cascade gene set 
(Table I), where TLR3, 7 and 8, involved in viral signaling, 
contributed to the enrichment score (23). In addition, several 
genes playing a role in viral signaling and interferon induction 
such as IFIH1, MAPK8, KPNA4 and IL18 genes were shown 
to be upregulated (Fig. 3).
Downstream of the activation of TLRs and interferons is 
the NF-κB signaling pathway, where EGAN analysis showed 
deregulation of IκB proteins (Table II). Overexpression of 
SH2D1A and IL18 (Fig. 7A), and CUL1 may indicate the posi-
tive regulation of NF-κB signaling (Fig. 3) (24-26).
Prostate cancer patients show induction of pro-inflammatory 
response via the activation of adaptive and innate immune 
signaling. Previously, we have demonstrated that low doses 
induce the activation of T- and B-cell receptors and innate-
related gene set, such as toll-like receptors, NOD-like 
receptors and RIG-like receptors (11). In agreement with these 
results, GSEA showed the enrichment of several gene sets that 
are involved in the stimulation of the immune response via the 
activation of both adaptive and innate immune responses. The 
second ranked immune gene set was CD28 stimulation, which 
is related also to the CTLA4 inhibition gene set (Table I). 
T cell activation is dependent on the opposing signaling from 
two cell receptors CD28 and CTL4A. Liu and colleagues (27) 
have reported that stimulation of CD28 is dose-dependent and 
specific to low doses of ionizing radiation. Furthermore, the 
same group reported upregulation in CD28 and downregula-
tion of CTLA4 in lymphocytes isolated from mouse blood 
exposed to 0.075 Gy whole body irradiation. They showed 
also that the interaction between antigen presenting cells and 
T cells is suppressed after exposure of mice to 2-Gy whole 
body irradiation as a result of CTLA4 upregulation (28). In 
addition, programmed death 1 (PD1) signaling was shown to 
be upregulated; PD1 is a surface membrane protein that plays 
a role in attenuating autoimmune responses, thus it acts in 
response to the increased activity of the T cell signaling (29). 
Other gene sets related to innate immune response and inflam-
mation were shown to be activated as well; these include 
phagosome pathway and inflammasome formation.
Prostate cancer patients show induction of pro-survival 
response via immune-stimulation and cell cycle progression 
responses downstream the growth factor signaling. There 
Figure 7. Comparative quantitative RT-PCR validation on genes differentially expressed. (A) Pro-inflammatory response stimulation (TLR3, SH2D1A and 
IL18); (B) cell cycle progression (ORC4, SMC2 and CCDC99); (C) DNA damage and repair (RAD17, SMC6 and MRE11A). Relative expression levels were 
calculated using Pffafl method normalized to PGK1 gene levels. Statistical comparison on the level of induction between the control and irradiated samples 
was done by applying paired t-test. A p<0.05 was considered as significant difference between the two conditions. *p<0.05, **p<0.005, ***p<0.0001. BI, before 
irradiation; AI, after irradiation.
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is growing evidence that low doses of ionizing radiation 
have a proliferative and pro-survival responses through the 
involvement of growth factors (11,30-32). Our data showed 
downregulation in several growth factors pathways, e.g. FGF, 
IGF-I and PDGF and several molecules involved in extracel-
lular matrix (ECM) molecules (e.g. LAMB3, COL20A1 and 
COL9A3) that are involved in growth signaling. This could 
be related to the late time-point. GSEA and EGAN analysis 
showed that the growth factor signaling cluster showed a 
connection with the adaptive immune response node and the 
viral response node; growth factors, such as FGF were previ-
ously shown to be involved in an immune-stimulatory reaction 
in response to lipopolysaccharide (LPS) stimulation (33,34). 
Furthermore, genes playing a role in the positive regulation of 
ERK, MAPK and NF-κB signaling were shown to be upregu-
lated, such as the induction of SOS1, ITGAV, AKT3, PIK3C2A, 
MAPK8, SH2D1A and IL18 (Figs. 3 and 5).
Furthermore, both analyses showed that viral and immune 
response gene sets were connected to the nodes of the cell 
cycle progression and DNA replication (Figs. 1, 6 and 7C). 
Previously, it was reported that regulation of cell cycle is a 
characteristic of a low dose response 24 h post-irradiation 
(9,10). In contrast to our expectation, cell cycle was not arrested 
and cell cycle checkpoints were not activated, probably due to 
the low doses received by the patients and the cell cycle posi-
tive regulation of the downstream growth factor and immune 
stimulation.
Prostate cancer patients show increased DNA damage and 
anti-apoptotic response post-IMRT. DNA damage signaling 
was induced 30 min post-irradiation (Table III) and did not 
terminate 18-24 h later (Figs. 3 and 7B). Taking into account 
that the cell cycle arrest was not activated (Fig. 4), and was 
shown not to be launched under a threshold of 200 mGy; this 
might increase the possibility of carrying unrepaired or misre-
paired DNA breaks through the cell division process, thus 
induction of cancers would be more probable (35,36). In addi-
tion, p53 signaling, which is known to be a central player in 
response to ionizing radiation (37), was not enriched in either 
analysis approach. The DNA damage and repair response 
was accompanied by an anti-apoptotic response; where genes 
involved in stabilization of p53 were downregulated (PHLDA3) 
(38) while others involved in its degradation were upregulated 
(MTBP) (39). BBC3, belongs to the BH3-only pro-apoptotic 
genes, and was also downregulated.
In conclusion, our study demonstrated that immune-
stimulatory signaling played a central role in response to low 
doses of ionizing radiation. These results are in agreement 
with those reported previously in our in vitro whole genome 
analysis (11). Furthermore, we showed that responses to low 
doses are a communication network between growth factors 
and cell cycle progression pathways stimulated by immune 
signaling. Moreover, we report that remaining unrepaired 
DNA damage still exists after 18-24 h.
Our study addresses the need for reconsideration of the 
health risks from the out-of-field low doses of ionizing radia-
tion exposed to the normal tissues when undergoing IMRT. 
Inflammatory and DNA damage responses may carry the risk 
of development of systematic inflammations and secondary 
cancers, respectively; there is accumulating number of studies 
that show advantages of using particle therapy over treatments 
that use X-rays. It is demonstrated that the healthy surrounding 
tissues are spared from out-field radiation. However, other 
studies have reported that secondary neutrons can carry the 
risk of developing secondary cancers during particle therapy. 
There are still no clear-cut answers for a ‘perfect’ radiotherapy 
approach, and further inter-disciplinary research is still 
required (7,40).
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